Asia Pacific Pen Needles Market Report

Asia Pacific Pen Needles Market Size

The Asia Pacific Pen needles market size was valued at USD 0.60 billion in 2025 and is anticipated to reach USD 0.68 billion in 2026 from USD 1.95 billion by 2034, growing at a CAGR of 14.10% during the forecast period from 2026 to 2034.

Growing in the preference for pen needles rather than syringes and vials, growth in geriatric populations are the key factor that drives the APAC pen needles market. Japan accounted for the largest share of the Asia-Pacific pen needles market in 2019, whereas India is estimated to grow at the highest CAGR during the forecast period.

The Chinese pen needles market is another promising region in the Asia Pacific market. Increasing diabetic patients in this region primarily drive the growth of the market in China. China is the country with the most massive diabetic patients worldwide, with around 116 million people suffering from diabetes. Overweight people are also highly susceptible to diabetes. According to the report, obesity is assumed to account for 80-85% of the risk of developing diabetes expected to drive the market growth in this region.

Indian pen needles market is predicted to grow at the highest CAGR from 2019 to 2024. The growth of the market is attributed to increasing awareness towards the availability of the latest technological devices for diabetes care, and the Indian government is also taking initiatives to spend on diabetes care and research to improve treatment techniques and methods for diabetic patients. Rising market penetration by key players and the development of improved pen needle technologies. For instance, Terumo Japan-based company has launched advanced Nanopass 34G- the world's thinnest double tapered pen needles.

REPORT COVERAGE

KEY MARKET PLAYERS

Some of the Companies that are dominating the APAC Pen Needles market include

• Becton Dickinson and Company
• Novo Nordisk A/S
• Ypsomed Holding AG (Switzerland)
• UltiMed, Inc.
• Allison Medical, Inc.
• Owen Mumford, Ltd.
• B. Braun Melsungen
• Artsana S.p.A.
• HTL-STREFA S.A.
• Terumo Corporation (Japan)

MARKET SEGMENTATION

This research report on the Asia Pacific Pen Needles Market has been segmented and sub-segmented into the following categories.

By Therapy

• Insulin Therapy
• GLP-1 Therapy
• Growth Hormone Therapy

By Type

• Standard Needle
• Safety Needle

By Needle Length

• 4mm
• 6mm
• 8mm
• 10mm
• 12mm

By Mode of Purchase

• Retail
• Non-Retail

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC